Package 50742-623-60

{"route": ["ORAL"], "spl_id": "723a8db6-baa2-47f7-a352-0ed4c25a184e", "openfda": {"nui": ["N0000175656", "N0000175462", "N0000009947"], "upc": ["0350742623600"], "unii": ["2T8Q726O95"], "rxcui": ["199147", "349491"], "spl_set_id": ["47f8be59-178c-4bad-96a4-a5c82784f308"], "pharm_class_epc": ["Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]", "Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]"], "pharm_class_moa": ["Nucleoside Reverse Transcriptase Inhibitors [MoA]"], "manufacturer_name": ["Ingenus Pharmaceuticals, LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "60 TABLET in 1 BOTTLE, PLASTIC (50742-623-60)", "package_ndc": "50742-623-60", "marketing_start_date": "20170201"}], "brand_name": "Lamivudine", "product_id": "50742-623_723a8db6-baa2-47f7-a352-0ed4c25a184e", "dosage_form": "TABLET", "pharm_class": ["Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]", "Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]", "Nucleoside Analog [EXT]", "Nucleoside Reverse Transcriptase Inhibitors [MoA]"], "product_ndc": "50742-623", "generic_name": "Lamivudine", "labeler_name": "Ingenus Pharmaceuticals, LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Lamivudine", "active_ingredients": [{"name": "LAMIVUDINE", "strength": "150 mg/1"}], "application_number": "ANDA206974", "marketing_category": "ANDA", "marketing_start_date": "20170201", "listing_expiration_date": "20261231"}